Mankind Pharma has acquired the rights to the Rivotril brand from Roche for the Indian market, marking a strategic expansion into chronic and specialty therapies. Rivotril, a widely prescribed formulation of clonazepam, is used in the treatment of neurological and psychiatric conditions. The deal grants Mankind Pharma exclusive authority to manufacture, market, and distribute the product across India.